Prevention of acute inducible atrial flutter in dogs by using an ibutilide-polymer-coated pacing electrode

Journal of Cardiovascular Pharmacology

Volumn 31, Issue 3, 1998, Pages 449-455

  Labhasetwar, Vinod ^a   Strickberger, S Adam ^a   Underwood, Thomas ^a   Davis, James ^a   Levy, Robert J ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Antiarrhythmic agent; Atrial arrhythmias; Ibutilide; Local drug delivery; Polymer; Sustained release

Indexed keywords

IBUTILIDE FUMARATE; POLYURETHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOG; DRUG COATING; DRUG DELIVERY SYSTEM; HEART ATRIUM FLUTTER; HEART ELECTROPHYSIOLOGY; HEART PACING; HEART SURGERY; NONHUMAN; PRIORITY JOURNAL; SINUS RHYTHM; SUSTAINED RELEASE PREPARATION;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DOGS; DRUG DELIVERY SYSTEMS; ELECTRODES; MICROSCOPY, ELECTRON, SCANNING; PACEMAKER, ARTIFICIAL; POLYMERS; SULFONAMIDES;

EID: 0031938040     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199803000-00017     Document Type: Article

References (41)

1. Lauer M, Eagle K, Buckley M, DeSanctis RW. Atrial fibrillation following coronary artery bypass surgery. Prog Cardiovasc Dis 1989;31:367-78.
2. Cox J. A perspective of postoperative atrial fibrillation in cardiac operations. Ann Thorac Surg 1993;56:405-9.
3. Muller G, Deal B, Strasburger J, Benson D Jr. Electrocardiographic features of atrial tachycardias after operation for congenital heart disease. Am J Cardiol 1993;71:122-24.
4. Prystowsky E, Benson D Jr, Fuster V, et al. Management of patients with atrial fibrillation. Circulation 1996;93:1262-77.
5. Labhasetwar V, Levy RJ. Polymer systems for cardiovascular drug delivery. Polymer News 1992;17:336-42.
6. Labhasetwar V, Kadish A, Underwood T, Sirinek M, Levy RJ. The efficacy of controlled release d-sotalol-polyurethane epicardial implants for ventricular arrythmias due to acute ischemia in dogs. J Control Release 1993;23:75-86.
7. Labhasetwar V, Underwood T, Gallagher M, Murphy G, Langberg J, Levy RJ. Sotalol controlled-release systems for arrhythmias: in vitro characterization, in vivo drug disposition, and electrophysiologic effects. J Pharm Sci 1994;83:157-64.
8. Labhasetwar V, Underwood T, Gallagher M, Langberg J, Levy RJ. Epicardial controlled release ibutilide: effects on defibrillation threshold and electrophysiologic parameters. J Cardiovasc Pharmacol 1994;24:826-40.
9. Labhasetwar V, Underwood T, Schwendeman S, Levy R. Iontophoresis for modulation of cardiac drug delivery. Proc Natl Acad Sci U S A 1995;92:2612-6.
10. Siden R, Kadish A, Flowers W, et al. Epicardial controlled-release verapamil prevents ventricular tachycardia episodes induced by acute ischemia in a canine model. J Cardiovasc Pharmacol 1992;19:798-809.
11. Sintov A, Scott W, Dick M, Levy RJ. Cardiac controlled release for arrhythmia therapy: lidocaine-polyurethane matrix studies. J Control Release 1988;8:157-65.
12. Sintov A, Scott WA, Siden R, Levy RJ. Efficacy of epicardial controlled-release lidocaine for ventricular tachycardia induced by rapid ventricular pacing in dogs. J Cardiovasc Pharmacol 1990;16:812-7.
13. Nabih MA, Prcevski P, Fromm BS, et al. Effect of ibutilide, a new class III agent, on sustained atrial fibrillation in a canine model of acute ischemia and myocardial dysfunction induced by microembolization. Pacing Clin Electrophysiol 1993;16:1975-83.
14. Buchanan L, Turcotte U, Kabell G, Gibson J. Antiarrhythmic and electrophysiologic effects of ibutilide in a chronic canine model of atrial flutter. J Cardiovasc Pharmacol 1993;33:10-4.
15. Buchanan L, Kabell G, Gibson J. Acute intravenous conversion of canine atrial flutter: comparison of antiarrhythmic agents. J Cardiovasc Pharmacol 1995;25:539-44.
16. + current in guinea pig ventricular cells. J Pharmacol Exp Ther 1992;262:99-108.
17. Lee KS, Lee EW. Membrane activities of class III antiarrhythmic compounds: a comparison between ibutilide, d-sotalol, E-4031, sematilide and dofetilide. Eur J Pharmacol 1993;234:43-53.
18. Buchanan LW, Kabell G, Brunden MN, Gibson JK. Comparative assessment of ibutilide, d-sotalol, clotilium, E-4031, and UK-68,798 in a rabbit model of proarrhythmia. J Cardiovasc Pharmacol 1993;220:540-9.
19. + current (IKr) in AT-1 cells: concentration-, time-, volt-age-, and use-dependent effects. Circulation 1995;91:1799-806.
20. Buchanan LV, Thompson DD, Hsu CL, Walters RR, Gibson JK. Antiarrhythmic and electrophysiologic effects of sublingual ibutilide fumarate. Drug Dev Res 1995;34:322-8.
21. DiMarco JP, VanderLugt JT, Lee KS, Gibson JK. Ibutilide. In: Singh BH, Wellens HJJ, Hiraoka M, eds. Electropharmacological control of cardiac arrythmias. Mount Kisco, NY: Futura Publishing Company, 1994:589-95.
22. Wesley R Jr, Farkhani F, Morgan D, Zimmerman D. Ibutilide: enhanced defibrillation via plateau sodium current activation. Am J Physiol 1993;264:H1269-74.
23. Buchanan LV, Kabell G, Turcotte UM, Brunden MN, Gibson JK. Effects of ibutilide on spontaneous and induced ventricular arrhythmias in 24-hour canine myocardial infarction: a comparative study with sotalol and encainide. J Cardiovasc Pharmacol 1992; 19:256-63.
24. Frame LH, Page RL, Hoffman BF. Atrial reentry around an anatomic barrier with a partially refractory excitable gap: a canine model of atrial flutter. Circ Res 1986;58:495-511.
25. Frame LH, Page RL, Boyden PA, Fenoglio JJ, Hoffman BF. Circus movement in the canine atrium around the tricuspid ring during experimental atrial flutter and during reentry in vitro. Circulation 1987;76:1155-75.
26. Hsu C, Walters R. Chiral separation of ibutilide enantiomers by derivatization with 1-naphthyl isocyanate and high-performance liquid chromatography in a Pirkle column. J Chromatogr 1991;550:621-8.
27. Levy RJ, Wolfrum J, Schoen FJ, Hawley MA, Langer R. Inhibition of calcification of bioprosthetic heart valves by local controlled-release diphosphonate. Science 1985;228:190-2.
28. Fram D, Aretz M, Mitchel J, et al. Localized intramural drug delivery during balloon angioplasty using hydrogel-coated balloons and pressure augmented diffusion. J Am Coll Cardiol 1994;23:1570-7.
29. Simons M, Edelman E, DeKeyser JL, Langer R, Rosenberg R. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature 1992;359:67-70.
30. Villa AE, Guzman LA, Chen W, Golomb G, Levy RJ, Topol EJ. Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty. J Clin Invest 1994;93:1243-9.
31. Villa A, Guzman L, Poptic E, et al. The effects of antisense c-myb oligonucleotides on vascular smooth muscle cell proliferation and response to vessel wall injury. Circ Res 1995;76:505-13.
32. Edelman ER, Adams DH, Karnovsky MJ. Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury. Proc Natl Acad Sci U S A 1990;87:3773-7.
33. Guzman L, Labhasetwar V, Song C, et al. Local intraluminal infusion of biodegradable polymeric nanoparticles: a novel approach for prolonged drug delivery after balloon angioplasty. Circulation 1996;94:1441-8.
34. Mond HG, Stokes KB. The electrode-tissue interface: the revolutionary role of steroid elution. Pacing Clin Electrophysiol 1992; 15:95-107.
35. Stokes KB, Graf JE, Weibusch WA. Drug eluting electrodes: improved pacemaker performance. IEEE Trans 1982;13:499-502.
36. Stokes KB, Kriett JM, Gornick CA, Betloff BLS, Benditt DG. Low threshold cardiac pacing electrodes. IEEE Trans 1983;5:100-3.
37. Johnston T, Webb CL, Schoen FJ, Levy RJ. Assessment of the in vitro transport parameters for ethanehydroxydiphosphonate through a polyurethane membrane: a potential refillable reservoir drug delivery device. ASAIO J 1992;38:M611-6.
38. Wilensky RL, March KL, Hathaway DR. Direct intraarterial wall injection of microparticles via a catheter: a potential drug delivery strategy following angioplasty. Am Heart J 1991;122:1136-40.
39. Wilensky RL, March KL, Gradus-Pizlo I, Spaedy AJ, Hathaway DR. Methods and devices for local drug delivery in coronary and peripheral arteries. Trends Cardiovasc Med 1993;3:163-70.
40. Stambler BS, Wood MA, Ellenbogen KA, Perry KT, Wakefield LK, VanderLugt JT. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Circulation 1996;94:1613-21.
41. Brown LR, Wei CL, Langer R. In vivo and in vitro release of macromolecules from polymeric drug delivery systems. Pharm Sci 1983;72:1181-5.